A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Comprehensive Cancer Center Bookmark and Share

Comprehensive Cancer Center

City of Hope has a proud history of excellence in biomedical research, patient-centered medical care, and community outreach.
 
In recognition of our broad-based innovations in cancer research and treatment, our continuing commitment to compassionate patient care, and our initiatives in patient and community education, the National Cancer Institute (NCI) has designated City of Hope a Comprehensive Cancer Center — the highest level of recognition bestowed by the NCI. City of Hope is one of just a handful of elite institutions nationwide to receive this prestigious honor.
 
As a division of the National Institutes of Health, the NCI is the Federal Government's principal agency for cancer research and training. The NCI's Cancer Center program acknowledges institutions for their scientific excellence, as well as their ability to bring diverse research approaches to the problem of cancer. The "Comprehensive Cancer Center" designation indicates that City of Hope has undergone a rigorous review process and has met or exceeded NCI standards in these areas.
 

City of Hope Comprehensive Cancer Center researchers and resources are dedicated to developing innovative new disease-fighting strategies in the battle against cancer. Through these programs, and through the mission and vision of City of Hope physicians and scientists, City of Hope Comprehensive Cancer Center will continue to make a difference in the lives of current and potential cancer patients and their loved ones—around the world today and in the future.
 
 
All of these activities are made possible by a forward-thinking infrastructure supporting basic and translational research in biological and small molecule cancer therapeutics.
 

Cancer Center Leadership

Cancer Center Program Co-leaders

About Our Cancer Center Research Programs

City of Hope provides a multidisciplinary, interactive environment where basic, clinical and translational, and prevention and control scientists collaborate closely. This stimulating intellectual environment contributes to the productive translational research under way within the Comprehensive Cancer Center. Our research initiatives are divided into the following research programs:
 
Basic Science Research Program

The Comprehensive Cancer Center provides both the infrastructure and the environment for outstanding basic science research. ("Basic science" refers to research conducted in a laboratory setting.) In turn, this research contributes to our understanding of the underlying genetic, molecular and biological bases of cancer. The basic science research program at City of Hope is called Molecular Oncology (MONC).
 
Clinical and Translational Research Programs

The Comprehensive Cancer Center's clinical and translational research programs focus on the translation of novel laboratory observations into the treatment of patients (and their families) and, ultimately, throughout the world. The number of the Center's novel (Phases I and I/II) clinical trials increases yearly. The clinical and translational science research programs are:
 
 
Prevention and Control Program
 
Cancer prevention and control research at the Comprehensive Cancer Center is conducted within a program on Cancer Control and Population Sciences (CCPS). The members of this research program cover an extensive spectrum of disciplines, which is further broadened by additional collaborations with physician investigators. Such a confederation of expertise, working within a collaborative environment, maximizes productive interaction. The program focuses on four important areas of concentration:
 
  • Host and environmental determinants of cancer
  • Health-related outcomes and quality of life after cancer
  • Interventional studies to reduce cancer-related morbidity
  • Educational initiatives
 
Our five research programs, described above, represent a continuum, as shown in the figure below. Basic and translational studies can originate in either the basic science program,MO or the DCT Program. These studies can then link to phase I and II clinical protocols in all three clinical programs—DCT, CI and HM. They can also integrate into follow-up studies in survivorship and symptom management in the CCPS Program. On this continuum, CI spans both translational and clinical research, whereas HM is predominantly (but not exclusively) clinical. Frequent interaction between the principal investigators of each program ensures maximum benefit from shared insights. All these activities are made possible by City of Hope’s infrastructure, which supports basic and translational research in biological and in small molecule approaches to cancer.

The arrow in the figure below represents our realization that, even as activities move to the right toward clinical realization, there is a strong requirement to recycle back to developmental activities in response to the knowledge we gain in early clinical application. Our scientists are already doing this routinely, aided by our flexible and responsive infrastructure. The CCPS Program also contributes to the cycle by providing downstream information on effects of therapy and also potential prevention and therapeutic targets — findings arising out of survivorship and molecular epidemiological work of CCPS. These findings may then be explored by other programs in the continuum.
 
 
 

Community Outreach

As a Comprehensive Cancer Center, City of Hope plays an important role in the community. We continually use the knowledge gained from our ongoing research to influence the standards of prevention and care, and to educate physicians, caregivers, and patients alike.
 
 

Why Choose a Comprehensive Cancer Center?

Only a National Cancer Institute (NCI)-designated Comprehensive Cancer Center such as City of Hope offers a full complement of services designed to address all aspects of cancer, from understanding its origins, to developing new therapies and testing them in patient clinical trials, to delivering superior patient care and providing support and education to patients, their families and the public.
 
City of Hope is one of a select few cancer centers nationwide to have received this prestigious honor. NCI-funded cancer centers must go through a rigorous review process every five years, in which they are evaluated and ranked. Only those conducting the most promising cancer research are awarded Comprehensive Cancer Center status. It is an important credential to consider when choosing a cancer treatment facility.
 
As a patient, a diagnosis of cancer brings with it many questions and concerns. Choosing a Comprehensive Cancer Center such as City of Hope is an empowering step, equipping you with the best possible resources to fight the disease.
 
Attributes of a Comprehensive Cancer Center
To achieve the Comprehensive Cancer Center designation, organizations must support a broad range of research programs and approach the problem of cancer in many different ways. Comprehensive Cancer Centers like City of Hope must have strong programs in all of the following areas:
 
Comprehensive Cancer Centers also play important roles in their communities and regions, and influence the standards of prevention and care.
 
National Comprehensive Cancer Network Founding Member
Of the relatively few NCI-designated Comprehensive Cancer Centers, only an elite 21 comprise the National Comprehensive Cancer Network ( NCCN ), an alliance of the nation's leading Comprehensive Cancer Centers that defines and sets standards for cancer care. City of Hope is proud to be a founding member of the NCCN. NCCN member institutions are recognized for their world-renowned experts and for dealing with particularly complex, rare and aggressive forms of cancer. As an NCCN member institution, City of Hope plays a critical role in advancing state-of-the-art cancer treatment through education, research, and patient care. Learn more about the NCCN at www.nccn.org.
 

Comprehensive Cancer Center

Comprehensive Cancer Center

City of Hope has a proud history of excellence in biomedical research, patient-centered medical care, and community outreach.
 
In recognition of our broad-based innovations in cancer research and treatment, our continuing commitment to compassionate patient care, and our initiatives in patient and community education, the National Cancer Institute (NCI) has designated City of Hope a Comprehensive Cancer Center — the highest level of recognition bestowed by the NCI. City of Hope is one of just a handful of elite institutions nationwide to receive this prestigious honor.
 
As a division of the National Institutes of Health, the NCI is the Federal Government's principal agency for cancer research and training. The NCI's Cancer Center program acknowledges institutions for their scientific excellence, as well as their ability to bring diverse research approaches to the problem of cancer. The "Comprehensive Cancer Center" designation indicates that City of Hope has undergone a rigorous review process and has met or exceeded NCI standards in these areas.
 

City of Hope Comprehensive Cancer Center researchers and resources are dedicated to developing innovative new disease-fighting strategies in the battle against cancer. Through these programs, and through the mission and vision of City of Hope physicians and scientists, City of Hope Comprehensive Cancer Center will continue to make a difference in the lives of current and potential cancer patients and their loved ones—around the world today and in the future.
 
 
All of these activities are made possible by a forward-thinking infrastructure supporting basic and translational research in biological and small molecule cancer therapeutics.
 

Cancer Center Leadership

Cancer Center Leadership

Cancer Center Program Co-leaders

Cancer Center Program Co-leaders

Cancer Center Research Programs

About Our Cancer Center Research Programs

City of Hope provides a multidisciplinary, interactive environment where basic, clinical and translational, and prevention and control scientists collaborate closely. This stimulating intellectual environment contributes to the productive translational research under way within the Comprehensive Cancer Center. Our research initiatives are divided into the following research programs:
 
Basic Science Research Program

The Comprehensive Cancer Center provides both the infrastructure and the environment for outstanding basic science research. ("Basic science" refers to research conducted in a laboratory setting.) In turn, this research contributes to our understanding of the underlying genetic, molecular and biological bases of cancer. The basic science research program at City of Hope is called Molecular Oncology (MONC).
 
Clinical and Translational Research Programs

The Comprehensive Cancer Center's clinical and translational research programs focus on the translation of novel laboratory observations into the treatment of patients (and their families) and, ultimately, throughout the world. The number of the Center's novel (Phases I and I/II) clinical trials increases yearly. The clinical and translational science research programs are:
 
 
Prevention and Control Program
 
Cancer prevention and control research at the Comprehensive Cancer Center is conducted within a program on Cancer Control and Population Sciences (CCPS). The members of this research program cover an extensive spectrum of disciplines, which is further broadened by additional collaborations with physician investigators. Such a confederation of expertise, working within a collaborative environment, maximizes productive interaction. The program focuses on four important areas of concentration:
 
  • Host and environmental determinants of cancer
  • Health-related outcomes and quality of life after cancer
  • Interventional studies to reduce cancer-related morbidity
  • Educational initiatives
 
Our five research programs, described above, represent a continuum, as shown in the figure below. Basic and translational studies can originate in either the basic science program,MO or the DCT Program. These studies can then link to phase I and II clinical protocols in all three clinical programs—DCT, CI and HM. They can also integrate into follow-up studies in survivorship and symptom management in the CCPS Program. On this continuum, CI spans both translational and clinical research, whereas HM is predominantly (but not exclusively) clinical. Frequent interaction between the principal investigators of each program ensures maximum benefit from shared insights. All these activities are made possible by City of Hope’s infrastructure, which supports basic and translational research in biological and in small molecule approaches to cancer.

The arrow in the figure below represents our realization that, even as activities move to the right toward clinical realization, there is a strong requirement to recycle back to developmental activities in response to the knowledge we gain in early clinical application. Our scientists are already doing this routinely, aided by our flexible and responsive infrastructure. The CCPS Program also contributes to the cycle by providing downstream information on effects of therapy and also potential prevention and therapeutic targets — findings arising out of survivorship and molecular epidemiological work of CCPS. These findings may then be explored by other programs in the continuum.
 
 
 

Community Outreach

Community Outreach

As a Comprehensive Cancer Center, City of Hope plays an important role in the community. We continually use the knowledge gained from our ongoing research to influence the standards of prevention and care, and to educate physicians, caregivers, and patients alike.
 
 

Why Choose A Comprehensive Cancer Center?

Why Choose a Comprehensive Cancer Center?

Only a National Cancer Institute (NCI)-designated Comprehensive Cancer Center such as City of Hope offers a full complement of services designed to address all aspects of cancer, from understanding its origins, to developing new therapies and testing them in patient clinical trials, to delivering superior patient care and providing support and education to patients, their families and the public.
 
City of Hope is one of a select few cancer centers nationwide to have received this prestigious honor. NCI-funded cancer centers must go through a rigorous review process every five years, in which they are evaluated and ranked. Only those conducting the most promising cancer research are awarded Comprehensive Cancer Center status. It is an important credential to consider when choosing a cancer treatment facility.
 
As a patient, a diagnosis of cancer brings with it many questions and concerns. Choosing a Comprehensive Cancer Center such as City of Hope is an empowering step, equipping you with the best possible resources to fight the disease.
 
Attributes of a Comprehensive Cancer Center
To achieve the Comprehensive Cancer Center designation, organizations must support a broad range of research programs and approach the problem of cancer in many different ways. Comprehensive Cancer Centers like City of Hope must have strong programs in all of the following areas:
 
Comprehensive Cancer Centers also play important roles in their communities and regions, and influence the standards of prevention and care.
 
National Comprehensive Cancer Network Founding Member
Of the relatively few NCI-designated Comprehensive Cancer Centers, only an elite 21 comprise the National Comprehensive Cancer Network ( NCCN ), an alliance of the nation's leading Comprehensive Cancer Centers that defines and sets standards for cancer care. City of Hope is proud to be a founding member of the NCCN. NCCN member institutions are recognized for their world-renowned experts and for dealing with particularly complex, rare and aggressive forms of cancer. As an NCCN member institution, City of Hope plays a critical role in advancing state-of-the-art cancer treatment through education, research, and patient care. Learn more about the NCCN at www.nccn.org.
 
Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Clinical Trials
Our aggressive pursuit to discover better ways to help patients now – not years from now – places us among the leaders worldwide in the administration of clinical trials.
 
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Discover the wide range of progressive cancer treatment options at City of Hope designed to meet the individual needs of each patient. Here, medical research and clinical care are integrated, speeding the application of scientific discoveries toward better, more effective patient cancer treatments.
City of Hope Breakthroughs
Get the latest in City of Hope's research, treatment and news you can use on our blog, Breakthroughs.
 
 
When you support City of Hope, you help us shorten the time it takes to get from bold, innovative ideas to powerful new medical treatments. Make a gift online now.


NEWS & UPDATES
  • Today is National Doctors Day, the official day to recognize, thank and celebrate the tremendous work physicians do each and every day. Launched in 1991 via a presidential proclamation from then-President George Bush, the observance offers a chance to reflect on the qualities that define truly great medical car...
  • When considering cancer risk, categories like “women’s cancers” and “men’s cancers” may not matter. A complete medical history, especially of first-degree relatives, must be considered when evaluating risk. A new study drives home that fact. Published in the journal Cancer, the study found a link between a fami...
  • Precision medicine holds promise – on that doctors, especially cancer specialists, can agree. But this sophisticated approach to treatment, which incorporates knowledge about a person’s genetic profile, environment and lifestyle, isn’t yet standard for all cancers. It can’t be. Researchers and scientists are st...
  • Frank Di Bella, 70, is on a mission: Find a cure for metastatic bladder cancer. It’s just possible he might. Although Di Bella isn’t a world-renowned physician, cancer researcher or scientist, he knows how to make things happen. For more than 20 years, he served as chairman of annual fundraising gal...
  • The physical side effects of cancer can damage anyone’s self-confidence, but especially that of women who, rightly or wrongly, are more likely to find their appearance (or their own perception of their appearance) directly connected to their ability to face the world with something resembling aplomb. Furt...
  • The promise of stem cell therapy has long been studied in laboratories. Now, as medicine enters an era in which this therapy will be increasingly available to patients, the nurses who help deliver it will be in the spotlight. City of Hope, which has launched its Alpha Clinic for Cell Therapy and Innovation (ACT...
  • Just because you can treat a condition, such as high cholesterol, at the end of life — well, that doesn’t mean you should. That’s the basic lesson of a study to be published March 30 in JAMA Internal Medicine. The ramifications go far beyond that. The research, in which City of Hope’s Betty Fe...
  • The understanding of the relationship between genetics and cancer risk continues to grow, with more genetic testing than ever before available to patients. However, the adage that a little knowledge is a dangerous thing is applicable: Without context for what a test result means, and without meaningful guidance...
  • Standard prostate biopsies haven’t changed significantly in the past 30 years – nor have the problems inherent with them. Regular biopsies have an expected error rate: Tumors may potentially be undersampled and, 30 percent of the time, men who undergo a radical prostatectomy are found to have more aggress...
  • In the field of cancer, patients have had surgery, chemotherapy and radiation therapy as options. Now, as City of Hope officially opens the Alpha Clinic for Cellular Therapy and Innovation, patients battling cancer and other life-threatening diseases have another option: stem-cell-based therapy. The Alpha Clini...
  • How does the environment affect our health? Specifically, how does it affect our risk of cancer? City of Hope physicians and researchers recently answered those questions in an Ask the Experts event in Corona, California, explaining the underlying facts about how the environment can affect our health. Moderator...
  • Nurses and other medical professionals have come to understand that it’s not enough just to fight disease. They also must provide pain relief, symptom control, and an unrelenting commitment to improve patients’ quality of life — especially at the end of life. Not too long ago, this was a relatively ...
  • “Tonight, I’m launching a new precision medicine initiative to bring us closer to curing diseases like cancer.” These were the words of President Barack Obama on Jan. 20, 2015, during his State of the Union address. So what is precision medicine, and how close are we to making it a reality for...
  • March is Colon Cancer Awareness Month. How sad, yet how serendipitous, that the co-creator of “The Simpsons” Sam Simon passed away in March after a four-year battle against colon cancer. What message can we all learn from his illness that can help us prevent and overcome colon cancer in our own lives? Colon can...
  • Misagh Karimi, M.D., assistant clinical professor, is a medical oncologist at one of City of Hope’s newest community practice locations, located in Corona in Riverside County. A recent community health report from Corona’s public health department stated that obesity rates for teens and adults in Riverside Coun...